26
Participants
Start Date
May 31, 2012
Primary Completion Date
November 30, 2014
Study Completion Date
July 1, 2019
rituximab
IV
bendamustine
IV
lenalidomide
PO
Mercy Medical Center-West Lakes, West Des Moines
Iowa Methodist Medical Center, Des Moines
Iowa Oncology Research Association CCOP, Des Moines
Medical Oncology and Hematology Associates-Des Moines, Des Moines
Medical Oncology and Hematology Associates, Des Moines
Mercy Medical Center - Des Moines, Des Moines
Iowa Lutheran Hospital, Des Moines
Medical Oncology and Hematology Associates-West Des Moines, Clive
Mercy Cancer Center-West Lakes, Clive
Mercy Medical Center-Sioux City, Sioux City
St. Luke's Regional Medical Center, Sioux City
Mayo Clinic, Rochester
Mid Dakota Clinic, Bismarck
Saint Alexius Medical Center, Bismarck
Sanford Bismarck Medical Center, Bismarck
Siouxland Hematology-Oncology, Sioux City
Methodist West Hospital, West Des Moines
Collaborators (1)
National Cancer Institute (NCI)
NIH
Celgene Corporation
INDUSTRY
Alliance for Clinical Trials in Oncology
OTHER